Cyanobacteria transposons have hairpin-shaped telomers ... a subfamily of telomere-targeting transposons that had utilized a CRISPR system. While CRISPR is typically utilized in bacteria to ...

Gene silencing is a negative feedback mechanism that regulates gene expression to define cell fate and also regulates metabolism and gene expression throughout the life of an organism. In plants, gene ...

Rather than being famous only in the gene editing field, by revealing the collateral cleavage activity of Cas12a, Cas13a, and Cas14 effectors, Clustered Regularly Interspaced Short Palindromic Repeats ...

This month's cover highlights the article Immune cells adapt to confined environments in vivo to optimise nuclear plasticity for migration by Helen Weavers and Tua Karling. The cover features confocal ...

Suffering on such an immense scale can appear hopeless. However, a technique called CRISPR gene editing promises to help deal with these issues and many more—and wise regulation can spur it on.

Clustered regularly interspaced short palindromic repeats/CRISPR-associated protein (CRISPR/Cas) technologies have evolved rapidly over the past decade with the continuous discovery of new Cas systems ...

Department of Computer Science, University of New Mexico, Albuquerque, New Mexico 87131, United States Center for Biomedical Engineering, University of New Mexico, Albuquerque, New Mexico 87131, ...

And it is at this intersection that the future of medicine is being written, with innovations like CRISPR and CAR-T therapy unlocking the potential to not only treat diseases but cure them.

Together, we intend to accelerate the field of next-generation medicines in mRNA and CRISPR, using best-in-class chemistries, processes, and proprietary technologies like CleanCap ® analogs ...

1 At conferences like Pittcon, where analytical chemistry and life science collide, CRISPR’s growing influence is unmistakable, taking a prominent place in the Bioanalytical & Life Sciences and ...

Crispr Therapeutics AG reported significant revenue declines in Q4 and FY24 due to reduced collaboration revenues, but maintains strong financial health with $298m cash and $1.6bn in marketable ...